grants awarded

St. Jude Children’s Research Hospital - $50,000 (July, 2009)

Phase I Study of the combination of Vandetanib and Dasatanib administered during and after radiation therapy in the children with newly diagnosed DIPG.
Grant Information
Website
Thank You Letter

Cincinnati Children’s Hospital Medical Center - $50,000 (July, 2009)

National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
Grant Information

St. Jude Children’s Research Hospital - $10,000 (July, 2009)
(in association with Smiles for Sophie Forever)

Second phase of genetic analysis of DIPG.
Grant Information
Thank You Letter

Cincinnati Children’s Hospital Medical Center - $50,000
(September, 2008)

Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
Grant Information

St. Jude Children’s Research Hospital - $25,000 (September, 2008)

A multi-institutional study in which an extensive analysis of the genetic make-up of brainstem gliomas will be performed to gain a better understanding of the underlying genetic abnormalities.
Grant Information
Thank You Letter